Targeting SPATS2 in lung adenocarcinoma: implications for prognosis and immune-based therapy.

Saved in:
Bibliographic Details
Title: Targeting SPATS2 in lung adenocarcinoma: implications for prognosis and immune-based therapy.
Authors: Teng M; Department of General Practice, the Affiliated Taizhou People's Hospital of Nanjing Medical University, No.366 Taihu Road, Taizhou Pharmaceutical High-tech Zone, Taizhou, 225300, Jiangsu, China., Yan F; Department of Pulmonary and Critical Care Medcine, Chengdu Institute of Respiratory Health, The Third People's Hospital of Chengdu, No. 82 Qinglong Street, Qingyang District, Chengdu, 610031, Sichuan, China., Shang J; Department of General Practice, the Affiliated Taizhou People's Hospital of Nanjing Medical University, No.366 Taihu Road, Taizhou Pharmaceutical High-tech Zone, Taizhou, 225300, Jiangsu, China., Sun X; Department of General Practice, the Affiliated Taizhou People's Hospital of Nanjing Medical University, No.366 Taihu Road, Taizhou Pharmaceutical High-tech Zone, Taizhou, 225300, Jiangsu, China., Wang Y; Department of General Practice, the Affiliated Taizhou People's Hospital of Nanjing Medical University, No.366 Taihu Road, Taizhou Pharmaceutical High-tech Zone, Taizhou, 225300, Jiangsu, China., Shen J; Department of Pulmonary and Critical Care Medcine, Chengdu Institute of Respiratory Health, The Third People's Hospital of Chengdu, No. 82 Qinglong Street, Qingyang District, Chengdu, 610031, Sichuan, China. sjfy20040320@163.com.
Source: Discover oncology [Discov Oncol] 2025 Aug 08; Vol. 16 (1), pp. 1504. Date of Electronic Publication: 2025 Aug 08.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2730-6011
DOI:10.1007/s12672-025-03179-7